Arca
Skip to content
Tools
Tools

FOLP1: Dihydropteroate synthase

Protein in Mycobacterium leprae (strain TN) that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on FOLP1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 2

Approved2

  • Dapsone
  • Sulfoxone

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DapsoneApprovedAlmirallSmall moleculeInhibitorDihydropteroate synthase 1 inhibitor5
        SulfoxoneApprovedAbbVieSmall moleculeInhibitorDihydropteroate synthase 1 inhibitor0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 5 in all, from ClinicalTrials.gov.
        A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)DapsonePhase 2 / Phase 3Not yet recruitingMerck Sharp & Dohme LLCNov 5, 2026
        Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)DapsonePhase 2Not yet recruitingFondation Raoul FollereauNov 5, 2026
        Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsDapsoneNot applicableRecruitingSouth Valley UniversityFeb 11, 2025
        Dermatitis Herpetiformis Refractory to Gluten Free DietDapsone—Enrolling by invitationTampere University HospitalAug 18, 2023
        A Randomized Multicenter Study for Isolated Skin VasculitisDapsonePhase 2RecruitingUniversity of PennsylvaniaOct 20, 2016

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2362993, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.